CMS Sees No “Systemic” Problems From Cancer Rx Payment Cuts
Executive Summary
CMS does not believe there is a "systemic access problem" to cancer therapies resulting from changes to Medicare reimbursement for Part B drugs in 2004, incoming Centers for Medicare & Medicaid Services Administrator Mark McClellan said